Prevalence, awareness, treatment and influence of socioeconomic variables on control of high blood pressure: Results of the ELSA-Brasil study

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Chor, Dóra ^a   Pinho Ribeiro, Antonio Luiz ^b   Sá Carvalho, Marilia ^a   Duncan, Bruce Bartholow ^c   Andrade Lotufo, Paulo ^d   Araújo Nobre, Aline ^a   De Aquino, Estela Mota Lima Leão ^e   Schmidt, Maria Inês ^c   Griep, Rosane Härter ^a   Molina, Maria Del Carmen Bisi ^f   Barreto, Sandhi Maria ^b   De Passos, Valéria Maria Azeredo ^b   Benseñor, Isabela Judith Martins ^d   Matos, Sheila Maria Alvim ^e   Mill, José Geraldo ^f  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^f FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; AMILORIDE; AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUMETANIDE PLUS FUROSEMIDE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CARVEDILOL; CHLORTALIDONE; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; LOOP DIURETIC AGENT; LOSARTAN; METOPROLOL; NIFEDIPINE; OLMESARTAN; PROPRANOLOL; RAMIPRIL; SPIRONOLACTONE; TELMISARTAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSARTAN; ANTIHYPERTENSIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AWARENESS; BRAZIL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPERTENSION; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; RACE DIFFERENCE; SELF CARE; SELF REPORT; SEX DIFFERENCE; SOCIAL STATUS; SOCIOECONOMICS;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; AWARENESS; BRAZIL; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; SOCIOECONOMIC FACTORS;

EID: 84939127951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127382     Document Type: Article

References (67)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2224-2260. doi: 10.1016/S0140-6736(12)61766-8 PMID: 23245609
2. World Health Organization. World health statistics 2012. Geneva: World Health Organization; 2012.
3. Lawes CM, Vander HS, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371: 1513-1518. doi: 10.1016/S0140-6736(08)60655-8 PMID: 18456100
4. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012; 380: 611-619. doi: 10.1016/S0140-6736(12)60861-7 PMID: 22883510
5. Paim J, Travassos C, Almeida C, Bahia L, Macinko J. The Brazilian health system: history, advances, and challenges. Lancet. 2011; 377: 1778-1797. doi: 10.1016/S0140-6736(11)60054-8 PMID: 21561655
6. Schmidt MI, Duncan BB, Azevedo e Silva, Menezes AM, Monteiro CA, Barreto SM, et al. Chronic noncommunicable diseases in Brazil: burden and current challenges. Lancet. 2011; 377: 1949-1961. doi: 10.1016/S0140-6736(11)60135-9 PMID: 21561658
7. Brazil Health Ministry. Information in Health-Vital Statistics [Internet]. 2013. Available: www.datasus.gov.br
8. Picon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC. Trends in Prevalence of Hypertension in Brazil: A Systematic Review with Meta-Analysis. Baradaran HR, editor. PLoS ONE. 2012; 7. doi: 10.1371/journal.pone.0048255
9. Moreira GC, Cipullo JP, Martin JFV, Ciorlia LAS, Godoy MRP, Cesarino CB, et al. Evaluation of the awareness, control and cost-effectiveness of hypertension treatment in a Brazilian city: populational study. J Hypertens. 2009; 27: 1900-1907. doi: 10.1097/HJH.0b013e32832dd10f PMID: 19587607
10. Yunis C, Krob HA. Status of health and prevalence of hypertension in Brazil. EthnDis. 1998; 8: 406-412. PMID: 9926912
11. Brazil Health Ministry. Vigitel Brasil 2011: Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico. Brasília: Ministério da Saúde; 2012.
12. Instituto Brasileiro de Geografia e Estatistica. Pesquisa nacional por amostra de domicílios (PNAD 2008), um panorama da Saúde no Brasil: acesso e utilização dos serviços, condições de saúde e fatores de risco e proteção ... saúde. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2010.
13. Nogueira D, Faerstein E, Coeli CM, Chor D, Lopes CS, Werneck GL. Awareness, treatment, and control of arterial hypertension: Pro-Saude study, Brazil. Rev PanamSaludPublica. 2010; 27: 103-109.
14. Pereira MR, Coutinho MS, Freitas PF, D'Orsi E, Bernardi A, Hass R. Prevalence, awareness, treatment, and control of hypertension in the adult urban population of Tubarao, Santa Catarina, Brazil, 2003. CadSaudePublica. 2007; 23: 2363-2374.
15. Gus I, Harzheim E, Zaslavsky C, Medina C, Gus M. Prevalence, awareness, and control of systemic arterial hypertension in the state of Rio Grande do Sul. ArqBrasCardiol. 2004; 83: 429-433.
16. Firmo JO, Uchoa E, Lima-Costa MF. The Bambui Health and Aging Study (BHAS): factors associated with awareness of hypertension among older adults. CadSaude Publica. 2004; 20: 512-521. PMID: 15073631
17. Ikeda N, Sapienza D, Guerrero R, Aekplakorn W, Naghavi M, Mokdad AH, et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. BullWorld Health Organ. 2014; 92: 10-19C. doi: 10.2471/BLT.13.121954
18. Moy E, Bartman BA, Weir MR. Access to hypertensive care. Effects of income, insurance, and source of care. Arch Intern Med. 1995; 155: 1497-1502. PMID: 7605151
19. De Gaudemaris R, Lang T, Chatellier G, Larabi L, Lauwers-Cancès V, Maître A, et al. Socioeconomic inequalities in hypertension prevalence and care: The IHPAF study. Hypertension. 2002; 39: 1119-1125. PMID: 12052852
20. Rose GA. The strategy of preventive medicine. Oxford [England]; New York: Oxford University Press; 1992.
21. Williams DR, Mohammed SA, Leavell J, Collins C. Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities. Ann N Y Acad Sci. 2010; 1186: 69-101. doi: 10.1111/j.1749-6632.2009.05339.x PMID: 20201869
22. Adler N, Bush NR, Pantell MS. Rigor, vigor, and the study of health disparities. Proc Natl Acad Sci. 2012; 109: 17154-17159. doi: 10.1073/pnas.1121399109 PMID: 23045672
23. Aquino EM, Barreto SM, Bensenor IM, Carvalho MS, Chor D, Duncan BB, et al. Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. AmJEpidemiol. 2012; 175: 315-324. doi: 10.1093/aje/kwr294 PMID: 22234482
24. Mill JG, Pinto K, Griep RH, Goulart A, Foppa M, Lotufo PA, et al. Afericoes e exames clinicos realizados nos participantes do ELSA-Brasil. Rev SaúdePública. 2013; 47: 54-62. doi: 10.1590/S0034-8910.2013047003851
25. O'Brien, Mee, Atkins, Thomas. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit. 1996; 1: 55-61. PMID: 10226203
26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA J Am Med Assoc. 2003; 289: 2560-2572. doi: 10.1001/jama.289.19.2560
27. Bensenor IM, Griep RH, Pinto KA, Faria CP de, Felisbino-Mendes M, Caetano EI, et al. Rotinas de organizacao de exames e entrevistas no centro de investigacao ELSA-Brasil. Rev Saúde Pública. 2013; 47: 37-47. doi: 10.1590/S0034-8910.2013047003780
28. Schmidt MI, Griep RH, Passos VM, Luft VC, Goulart AC, Menezes GM de S, et al. Estrategias e desenvolvimento de garantia e controle de qualidade no ELSA-Brasil. Rev Saúde Pública. 2013; 47: 105-112. doi: 10.1590/S0034-8910.2013047003889
29. Chor D, Alves MG de M, Giatti L, Cade NV, Nunes MA, Molina M del CB, et al. Questionario do ELSA-Brasil: desafios na elaboracao de instrumento multidimensional. Rev SaúdePública. 2013; 47: 27-36. doi: 10.1590/S0034-8910.2013047003835
30. Wilcosky TC, Chambless LE. A comparison of direct adjustment and regression adjustment of epidemiologic measures. J Chronic Dis. 1985; 38: 849-856. PMID: 4044770
31. Flanders WD, Rhodes PH. Large sample confidence intervals for regression standardized risks, risk ratios, and risk differences. J Chronic Dis. 1987; 40: 697-704. PMID: 3597672
32. Bastos L, Oliveira R, Velasque L. Obtaining adjusted prevalence ratios from logistic regression model in cross-sectional studies. Cad SaúdePública. 2015;
33. Team RC. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2013. Available: http://www.R-project.org/
34. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013; 1-8.
35. Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension. 2009; 53: 480-486. doi: 10.1161/HYPERTENSIONAHA.108.125617 PMID: 19204180
36. Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study. Bull World Health Organ. 2014; 92: 29-41. doi: 10.2471/BLT.13.124495 PMID: 24391298
37. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am CollCardiol. 2012; 60. doi: 10.1016/j.jacc.2012.04.026
38. McAlister FA, Wilkins K, Joffres M, Leenen FHH, Fodor G, Gee M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ Can Med Assoc J JAssocMedicale Can. 2011; 183: 1007-1013. doi: 10.1503/cmaj.101767
39. Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension. 2013; 62: 18-26. doi: 10.1161/HYPERTENSIONAHA.113.01374 PMID: 23670299
40. Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton PK, et al. Factors Associated with Hypertension Awareness, Treatment, and Control in a Representative Sample of the Chinese Population. Hypertension. 2004; 43: 578-585. PMID: 14744929
41. Wyatt SB, Akylbekova EL, Wofford MR, Coady SA, Walker ER, Andrew ME, et al. Prevalence, awareness, treatment, and control of hypertension in the Jackson Heart Study. Hypertension. 2008; 51: 650-656. doi: 10.1161/HYPERTENSIONAHA.107.100081 PMID: 18268140
42. Ordúñez P, Kaufman JS, Benet M, Morejon A, Silva LC, Shoham DA, et al. Blacks and Whites in the Cuba have equal prevalence of hypertension: confirmation from a new population survey. BMC Public Health. 2013; 13. doi: 10.1186/1471-2458-13-169
43. Lloyd-Sherlock P, Beard J, Minicuci N, Ebrahim S, Chatterji S. Hypertension among older adults in low-and middle-income countries: prevalence, awareness and control. Int J Epidemiol. 2014; 43: 116-128. doi: 10.1093/ije/dyt215 PMID: 24505082
44. Travassos C, Viacava F, Pinheiro R, Brito A. Utilização dos serviços de saúde no Brasil: gênero, características familiares e condição social. Rev Panam Salud Pública. 2002; 11: 365-373. doi: 10.1590/S1020-49892002000500011
45. Vitale C, Miceli M, Rosano GMC. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric J Int Menopause Soc. 2007; 10Suppl 2: 16-20. doi: 10.1080/13697130701602712
46. Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens EJM, Pyörälä K, et al. Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia. 2004; 47: 1245-1256. doi: 10.1007/s00125-004-1433-4 PMID: 15241592
47. Elder K, Ramamonjiarivelo Z, Wiltshire J, Piper C, Horn WS, Gilbert KL, et al. Trust, medication adherence, and hypertension control in Southern African American men. Am J Public Health. 2012; 102: 2242-2245. doi: 10.2105/AJPH.2012.300777 PMID: 22698017
48. Maimaris W, Paty J, Perel P, Legido-Quigley H, Balabanova D, Nieuwlaat R, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med. 2013; 10. doi: 10.1371/journal.pmed.1001490
49. Carrington MJ, Jennings GL, Stewart S. Pressure points in primary care: blood pressure and management of hypertension in 532 050 patients from 2005 to 2010. J Hypertens. 2013; 31: 1265-1271. doi: 10.1097/HJH.0b013e3283606bc7 PMID: 23552128
50. Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJG, Phillips BB, Zimmerman MB, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006; 47: 352-358. doi: 10.1161/01.HYP.0000203309.07140.d3 PMID: 16432050
51. Fasce E, Campos I, Ibáñez P, Flores M, Zárate H, Román O, et al. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens. 2007; 25: 1807-1811. PMID: 17762644
52. Schmidt MI, Duncan BB, Mill JG, Lotufo PA, Chor D, Barreto SM, et al. Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil). Int J Epidemiol. 2014; doi: 10.1093/ije/dyu027
53. Ong KL, Cheung BMY, Man YB, Lau CP, Lam KSL. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007; 49: 69-75. doi: 10.1161/01.HYP.0000252676.46043.18 PMID: 17159087
54. Umscheid CA, Gross R, Weiner MG, Hollenbeak CS, Tang SSK, Turner BJ. Racial disparities in hypertension control, but not treatment intensification. Am J Hypertens. 2010; 23: 54-61. doi: 10.1038/ajh.2009.201 PMID: 19893494
55. Smith PM, Mustard CA, Lu H, Glazier RH. Comparing the risk associated with psychosocial work conditions and health behaviours on incident hypertension over a nine-year period in Ontario, Canada. Can J Public Health. 2013; 104. Available: http://go.galegroup.com.ez68.periodicos.capes.gov.br/ps/i.do?id=GALE%7CA339015437&v=2.1&u = capes58&it = &p=AONE&sw = w&asid = bb4404d887a6c2ae4359a2c388c44265
56. Mozumdar A, Liguori G. Statewide awareness study on personal risks of cardiovascular disease in women: a go red North Dakota study. Womens Health Lond Engl. 2010; 6: 37-50. doi: 10.2217/whe.09.78 PMID: 20088728
57. Mosca L, Mochari H, Christian A, Berra K, Taubert K, Mills T, et al. National study of women's awareness, preventive action, and barriers to cardiovascular health. Circulation. 2006; 113: 525-534. doi: 10.1161/CIRCULATIONAHA.105.588103 PMID: 16449732
58. Carroll-Scott A, Gilstad-Hayden K, Rosenthal L, Peters SM, McCaslin C, Joyce R, et al. Disentangling neighborhood contextual associations with child body mass index, diet, and physical activity: the role of built, socioeconomic, and social environments. SocSci Med 1982. 2013; 95: 106-114. doi: 10.1016/j.socscimed.2013.04.003
59. Kuzawa CW, Sweet E. Epigenetics and the embodiment of race: Developmental origins of US racial disparities in cardiovascular health. Am J Hum Biol. 2009; 21: 2-15. doi: 10.1002/ajhb.20822 PMID: 18925573
60. Dolezsar CM, McGrath JJ, Herzig AJM, Miller SB. Perceived racial discrimination and hypertension: A comprehensive systematic review. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2014; 33. doi: 10.1037/a0033718
61. Sims M, Diez-Roux AV, Dudley A, Gebreab S, Wyatt SB, Bruce MA, et al. Perceived discrimination and hypertension among African Americans in the Jackson Heart Study. Am J Public Health. 2012; 102 Suppl 2: S258-265. doi: 10.2105/AJPH.2011.300523 PMID: 22401510
62. Sichieri R, Oliveira MC, Pereira RA. High prevalence of hypertension among Black and Mulatto women in a Brazilian survey. Ethn Dis. 2001; 11: 412-418. PMID: 11572407
63. Lotufo PA, Bensenor IJM. Raca e mortalidade cerebrovascular no Brasil. Rev Saúde Pública. 2013; 47: 1201-1204. doi: 10.1590/S0034-8910.2013047004890
64. Chor D, Lima CR de A. Aspectos epidemiológicos das desigualdades raciais em saúde no Brasil. Cad SaúdePública. 2005; 21: 1586-1594.
65. Faerstein E, Chor D, Werneck GL, Lopes C de S, Kaplan G. Race and perceived racism, education, and hypertension among Brazilian civil servants: the Pró-Saúde Study. Rev Bras Epidemiol. 2014; 17: 81-87. doi: 10.1590/1809-4503201400060007 PMID: 25409639
66. Phillips SP. Including gender in public health research. Public Health Rep Wash DC 1974. 2011; 126Suppl 3: 16-21. PMID: 21836732
67. Mancia G. Blood pressure control in the hypertensive population. Is the trend favourable? J Hypertens. 2013; 31: 1094-1095. doi: 10.1097/HJH.0b013e32836184cf PMID: 23636017